---
title: Direct neuronal protection by the protease-activated receptor PAR4 antagonist
  ML354 after experimental stroke in mice
date: '2024-05-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38760890/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240519182240&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND IMPLICATIONS: Selective PAR4 inhibition during reperfusion
  improves infarct size and neurological function after experimental stroke by blunting
  neuronal excitability, apoptosis, and local inflammation. PAR4 antagonists may provide
  additional neuroprotective benefits in patients with acute stroke beyond their canonical
  antiplatelet ...'
disable_comments: true
---
CONCLUSIONS AND IMPLICATIONS: Selective PAR4 inhibition during reperfusion improves infarct size and neurological function after experimental stroke by blunting neuronal excitability, apoptosis, and local inflammation. PAR4 antagonists may provide additional neuroprotective benefits in patients with acute stroke beyond their canonical antiplatelet ...